Distribution of cardiac troponin I in the Japanese general population and factors influencing its concentrations

Journal of Clinical Laboratory Analysis

Volumn 32, Issue 3, 2018, Pages

  Abe, Naoya ^a   Tomita, Kenichiro ^a   Teshima, Mayumi ^a   Kuwabara, Maki ^a   Sugawa, Satoshi ^b   Hinata, Nae ^c   Matsuura, Masaaki ^d,e   Fujiwara, Mutsunori ^a   Takaya, Kazuhiko ^a   Hiyoshi, Toru ^a   Uozumi, Hiroki ^a   Ikenouchi, Hiroshi ^a   Ishikawa, Rie ^a   Shojima, Junko ^a   Komatsu, Junko ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b Abbott Japan Co Ltd   (Japan)

^c TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^d CANCER CHEMOTHERAPY CENTER   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

Author keywords

99th percentile; cardiovascular risk; general population; health checkup; high sensitive troponin

Indexed keywords

C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH SENSITIVE C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BODY MASS; CORRELATIONAL STUDY; ECG ABNORMALITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GERMANY; HUMAN; IMMUNOASSAY; JAPAN; JAPANESE (PEOPLE); LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MIDDLE AGED; NORMAL HUMAN; POPULATION RESEARCH; RISK FACTOR; SINGAPORE; UNITED STATES; BLOOD; EPIDEMIOLOGY; HEART INFARCTION; REFERENCE VALUE; STANDARDS; STATISTICAL MODEL;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; JAPAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; REFERENCE VALUES; TROPONIN I;

EID: 85026543866     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22294     Document Type: Article

References (15)

1. Ministry of Health, Labour and Welfare. Annual Health, Labour and Welfare Report. Japan: Ministry of Health, Labour and Welfare; 2014.
2. Ministry of Health, Labour and Welfare. Vital Statistics of Japan. Tokyo, Japan: Ministry of Health, Labour and Welfare; Dec. 5, 2016.
3. de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA. 2013;309:2262-2269.
4. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. JACC. 2012;60:1581-1598.
5. Amsterdam EA, Wenger NK, Brandis RG, et al. 2014 AHA/ACC guideline for the management of patients with Non–ST-Elevation acute coronary syndromes. JACC. 2014;64:e139-e228.
6. Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin Chim Acta. 2013;422:26-28.
7. Zeller T, Ojeda F, Brunner FJ, et al. High-sensitivity cardiac troponin I in the general population–defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med. 2015;53:699-706.
8. ARCHITECT STAT High Sensitive Troponin-I PI, B3P250, G1-0139/R02, Abbott Laboratories.
9. Zeller T, Tunstall-Pedoe H, Saarela O, et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J. 2014;35:271-281.
10. Ridker PM. C-Reactive protein and the prediction of cardiovascular events among those at intermediate risk. JACC. 2007;49:2129-2138.
11. Everett BM, Zeller T, Glynn RJ, et al. High-sensitivity cardiac troponin I and B-type natriuretic peptide as predictors of vascular events in primary prevention impact of statin therapy. Circulation. 2015;131:1851-1860.
12. Horowitz GL, Altaie S, Boyd JC. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd edn. C28-A3c. Wayne, PA, USA: The Clinical and Laboratory Standards Institute; 2010;28.
13. hsCRPDL-OQIY GCardioPhase 113-031G (21 E11), Siemens Healthcare Diagnostics, Inc.
14. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
15. Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu Rev Physiol. 2009;71:1-18.